Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
about
Modern imaging techniques for preoperative detection of distant metastases in gastric cancerReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applicationsPrognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma.Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast CancerPrognostic Significance of Volume-based Metabolic Parameters by (18)F-FDG PET/CT in Gallbladder Carcinoma.Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis?Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer.GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugatesUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer?SUVmax/THKmax as a biomarker for distinguishing advanced gastric carcinoma from primary gastric lymphomaJapanese Gastric Cancer Association Task Force for Research Promotion: clinical utility of ¹⁸F-fluoro-2-deoxyglucose positron emission tomography in gastric cancer. A systematic review of the literature.Diagnosis and evaluation of gastric cancer by positron emission tomographyThe role of 2-[f-18] fluoro 2-deoxy d-glucose positron emission tomography in the preoperative staging of gastric cancerCurcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathwayClinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.Expression of hypoxic markers and their prognostic significance in soft tissue sarcomaCurrent concepts on dedifferentiation/high-grade transformation in salivary gland tumors.GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis.The Role of 18F-FDG PET/CT in the Primary Staging of Gastric Cancer¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.Correlation of Primary Tumor FDG Uptake with Histopathologic Features of Advanced Gastric Cancer.Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric CancerMicroenvironmental and cellular consequences of altered blood flow in tumours.Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.Predictive Role of the Number of 18F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer.Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients.Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis.[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.Evaluation of FLT-PET/CT usefulness in diagnosis and qualification for surgical treatment of gastric cancer.The role of positron emission tomography in esophageal cancer.
P2860
Q26784453-CAC1F999-0B2F-4F3B-921A-50BF11BF87DFQ28077883-04B0DE63-8DBA-4409-9EA4-3F40557226C7Q28389539-9B632F90-323C-418A-8906-13D6AB3A95F5Q30241566-8121286A-EF27-4A79-B6D2-A2E828D169CFQ33583028-2ABB8F1E-5F6A-4547-9D52-8AA561C73019Q33704181-EEAAA5FF-F3B3-4FDE-8925-2A694670B4D6Q33704435-8BC4A5CF-B14E-4E7E-84F4-4B09403A5863Q33704511-AC2D2B42-B622-4013-B4AD-6F7F934D20C2Q33714473-7CBAD380-ED5D-4F82-B9C8-85E6ADDBBA50Q33727137-2E1182DA-5DB8-49D5-A795-9D652BA9350BQ33889236-E563F7B8-2BF8-4A39-98CA-DBC9BC260AA9Q34204238-B0F2923E-B0F8-4B7B-84E0-6AB613C33AA2Q34310486-4A32B05A-2A83-4283-8826-A14919D5729DQ34326615-676BC958-FB45-460E-BF04-9C6B3499FD32Q34506646-01DDABAB-1E79-4E1B-A4D3-1ADAF8F4D850Q34627053-D0FA6606-C812-4C20-B886-08D28C835681Q34661633-C8090F9B-3A79-422D-8D81-4C966E3DDB31Q34666869-36E97E4E-CBEA-474B-92E6-C85727D6D743Q34672640-730BB2D1-18AD-4929-B35E-737A3C02F647Q34831255-E4156F13-7439-4F49-A79A-CE22D988FEE3Q35127213-F398CCBB-29AA-4AE6-955F-FECB0AC564D2Q35167655-BD30BAD6-4CE5-4FBB-AD13-844BEEC1E72AQ35176500-CE680404-04BB-493D-B81A-8197604C3088Q35188024-21C747FE-78D1-45F9-9988-F30D3C93C92EQ35214843-A433CD75-DBD6-42C3-ACCD-1AB8D0AB388AQ35670459-A71D38AD-E19F-4168-BB9E-5247A6D2D2C8Q35724980-96A35B2F-76B6-436D-9123-0A523228593BQ35857879-38F25F29-F269-4D4C-AADD-24D0186BE44CQ35902612-0CDD4749-89DE-4DE4-BAE1-01283DA0F4A4Q35904989-055E0601-95B9-48FC-98C7-E16355BEA6F0Q35928789-318FDB67-F444-49F7-BFC1-507001FAC6D5Q36064169-00C4086E-B5C6-4B69-9E58-4F8E8D75A520Q36142620-839153B8-4238-4F66-80DF-EFDAC40240D0Q36218208-5AC465F5-EAEF-4298-92F6-9A263F257C5EQ36319461-671C0E52-6AA5-4E0E-B891-5F729E253057Q36323245-3B56A44B-F5FC-4201-A7B3-B43123AE93F0Q36494154-C5E54A02-298D-4B64-BA0F-50B57DFB1863Q36901233-09C19914-04D6-40A4-AC9A-36A2A81DABD6Q36936849-91110F94-7F99-4C91-A2C4-E71F8ECD364DQ37072481-43F8A14A-97EB-4862-B4D6-7F4B290DC9FA
P2860
Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Expression of glucose transpor ...... astasis, and patient survival.
@en
Expression of glucose transpor ...... astasis, and patient survival.
@nl
type
label
Expression of glucose transpor ...... astasis, and patient survival.
@en
Expression of glucose transpor ...... astasis, and patient survival.
@nl
prefLabel
Expression of glucose transpor ...... astasis, and patient survival.
@en
Expression of glucose transpor ...... astasis, and patient survival.
@nl
P2093
P2860
P921
P1433
P1476
Expression of glucose transpor ...... astasis, and patient survival.
@en
P2093
Kawamura T
Kusakabe T
Nashimoto A
Watanabe K
P2860
P304
P356
10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X
P407
P577
2001-08-01T00:00:00Z